Effects of HLA-matched blood transfusion for patients awaiting renal transplantation

Transplantation

Volumn 94, Issue 11, 2012, Pages 1111-1116

  Magee, Bernadette A ^a   Martin, Jeanie ^a   Cole, Miceal P ^a   Morris, Kieran G ^a   Courtney, Aisling E ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Antibody sensitization; HLA matched blood; HLAmatchmaker; Renal transplantation

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PANEL REACTIVE ANTIBODY;

ADULT; ALGORITHM; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CELL SELECTION; CHILD; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; IMMUNOGENICITY; KIDNEY TRANSPLANTATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIZATION;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; WAITING LISTS;

EID: 84871621430     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318271d776     Document Type: Article

References (20)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
2. Cardella CJ. The use of the kidney with an historical positive, and current negative crossmatch. Pediatr Nephrol 1991; 5: 126.
3. Reinsmoen NL, Lai CH, Vo A, et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitisation therapy. Transplantation 2008; 86: 820.
4. Everett ET, Kao KJ, Scornik JC. Class I molecules on human ery-throcytes: quantitation and transfusion effects. Transplantation 1987; 44: 123.
5. Middleton D, Martin J, Magee BA, et al. Effect on sensitisation on giving HLA-DR-Matched blood to potential renal transplant recipients. Transplant Proc 1992; 24: 2535.
6. Middleton D, Martin J, Douglas J, et al. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994; 58: 845.
7. British Bone Marrow Registry. Available at: http://www.nhsbt.nhs.uk/ bonemarrow. Accessed October 16, 2012.
8. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63: 339.
9. Scornik JC, Brunson ME, Howard RJ, et al. Alloimmunisation, memory and the interpretation of crossmatch results for renal transplantation. Transplantation 1992; 54: 389.
10. Scornik JC, Schold JD, Bucci M, et al. Effects of blood transfusions given after renal transplantation. Transplantation 2009; 87: 1381.
11. Van de Watering L, Hermans J, Witvliet M, et al. HLA and RBC immunisation after filtered and buffy coat-depleted transfusion in cardiac surgery: a randomised controlled trial. Transfusion 2003; 43: 765.
12. Massad MG, Cook DJ, Schmitt SK, et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997; 64: 1120.
13. Reisner EG, Koystu DD, Phillips G, et al. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987; 30: 161.
14. Scornik JC, Meier-Kriesche HU. Blood transfusion in organ transplant patients: mechanisms of sensitisation and implications for prevention. Am J Transplant 2011; 11: 1785.
15. Burlingham WJ, Stratta R, Mason B, et al. Risk factors for sensitiza-tion by blood transfusion. Comparison of UW/Madison and UC/San Francisco donor-specific transfusion experience. Transplantation 1989; 47: 140.
16. Scornik JC, Salomon DR, Howard RJ, et al. Prevention of transfusion-induced broad sensitization in renal transplant candidates. Transplantation 1989; 47: 617.
17. British Transplantation Society/The Renal Association. United Kingdom Guidelines for Living Donor Kidney Transplantation-Third Edition May 2011. 7.2 Identification and characterisation of alloantibodies. Available at: http://www.bts.org.uk and http://www.renal.org. Accessed October 16, 2012.
18. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313.
19. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 65: 12.
20. Duquesnoy RJ, Howe J, Takemoto S. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitised patients. Transplantation 2003; 75: 889.